PATENT CLAIM ANALYSIS

Application Number: 16061248
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "450000"]

Abstract:
A pharmaceutical formulation for delivery of a therapeutic agent having a metal complexation moiety and a solubility in water or a metal ion solution of less than 1 mg/ml. The formulation includes the therapeutic agent and a metal ion complexed inside a lipid-based nanoparticle formulation.

Claim (Index 48):
The formulation of  claim 44 , wherein the poorly soluble therapeutic agent comprising the metal complexation moiety is selected from the group consisting of clioquinol, diethyldithiocarbamate, quercetin and CX5461.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 94.0
- Lexical Diversity: 1.46875
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11842130', '10264818', '15502092', '15216416', '14302537']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7541941986410269
- 35 USC 102 Novelty (BERT): 0.5277991230419954
- Combined Prediction Score: 0.7315546910811237
- Mean Citation Score: 317.634
- Max Citation Score: 345.28876
- Similarity Product: 205.7508830231237

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test